clinical trial · NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
H. Lundbeck A/S·phase3·recruiting·n = 315
Episodic MigraineEptinezumabPlacebo
brief summary
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
started
Jun 8, 2023
primary completion
Jul 6, 2027
completion
Aug 31, 2027
last updated
Jul 14, 2026
official title
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol